Chapter 14. Steroids and Asparaginases During Remission Induction Therapy in Childhood Lymphoblastic Leukemia

  1. Ross Pinkerton1,
  2. Katherine Matthay3,
  3. AG Shankar2 and
  4. Katherine Matthay3

Published Online: 4 OCT 2007

DOI: 10.1002/9780470987148.ch14

Evidence-based Pediatric Oncology, Second Edition

Evidence-based Pediatric Oncology, Second Edition

How to Cite

Pinkerton, R., Matthay, K., Shankar, A. and Matthay, K. (eds) (2007) Steroids and Asparaginases During Remission Induction Therapy in Childhood Lymphoblastic Leukemia, in Evidence-based Pediatric Oncology, Second Edition, Blackwell Publishing, Oxford, UK. doi: 10.1002/9780470987148.ch14

Editor Information

  1. 1

    Childrens Cancer Unit, Mater Childrens Hospital, Raymond Terrace, Brisbane, Australia

  2. 2

    Department of Paediatric and Adolescent Oncology, University College of London NHS Trust, London, UK

  3. 3

    Department of Pediatric Oncology, University of California at San Francisco, San Francisco, CA, USA

Publication History

  1. Published Online: 4 OCT 2007
  2. Published Print: 13 APR 2007

ISBN Information

Print ISBN: 9781405142687

Online ISBN: 9780470987148

SEARCH

Keywords:

  • steroids;
  • asparaginases;
  • remission induction therapy (RIT);
  • toxicity;
  • relapse

Summary

This chapter contains sections titled:

  • Study 1

  • Study 2

  • Study 3

  • Study 4

  • Study 5

  • Study 6

  • Study 7

  • Study 8